Abiopharma

🔍 RANKIN ALISON A (Executive)

Company: Hamilton Beach Brands Holding Co (HBB)

Report Date: 2026-05-29

Detailed Transactions and Holdings:

• Acquired 1,390 shares of Class B Common Stock (Derivative)
  Date: 2026-05-29 | Code: G | equity_swap_involved: 0 | shares_owned_after: 46,239.00 | transaction_form_type: 5 | Footnotes: F1, F1, F1, F1, F2
• Acquired 1,390 shares of Class B Common Stock (Derivative)
  Date: 2026-05-29 | Code: G | equity_swap_involved: 0 | shares_owned_after: 50,014.00 | transaction_form_type: 5 | Footnotes: F1, F1, F1, F1, F2
• Sold 2,780 shares of Class B Common Stock (Derivative)
  Date: 2026-05-29 | Code: G | equity_swap_involved: 0 | shares_owned_after: 378,212.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1
• Holds 20,096 shares of Class B Common Stock (Derivative)
  Date: 2026-05-29 | Code: H | shares_owned_after: 20,096.00 | Footnotes: F1, F1, F1, F2
• Holds 20,096 shares of Class B Common Stock (Derivative)
  Date: 2026-05-29 | Code: H | shares_owned_after: 20,096.00 | Footnotes: F1, F1, F1, F2
• Holds 18,861 shares of Class B Common Stock (Derivative)
  Date: 2026-05-29 | Code: H | shares_owned_after: 18,861.00 | Footnotes: F1, F1, F1, F2
• Holds 18,861 shares of Class B Common Stock (Derivative)
  Date: 2026-05-29 | Code: H | shares_owned_after: 18,861.00 | Footnotes: F1, F1, F1, F2
• Holds 3,950 shares of Class B Common Stock (Derivative)
  Date: 2026-05-29 | Code: H | shares_owned_after: 3,950.00 | Footnotes: F1, F1, F1, F3
• Holds 4,061 shares of Class B Common Stock (Derivative)
  Date: 2026-05-29 | Code: H | shares_owned_after: 4,061.00 | Footnotes: F1, F1, F1, F3
• Holds 248,079 shares of Class B Common Stock (Derivative)
  Date: 2026-05-29 | Code: H | shares_owned_after: 248,079.00 | Footnotes: F1, F1, F1, F3

Footnotes:

• F1: N/A
• F2: Reporting Person disclaims beneficial ownership of all such shares.
• F3: Reporting Person disclaims beneficial ownership of these shares except to the extent of her pecuniary interest therein.